JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Scope & Guideline

Transforming cancer care through dedicated pharmaceutical research.

Introduction

Welcome to the JOURNAL OF ONCOLOGY PHARMACY PRACTICE information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of JOURNAL OF ONCOLOGY PHARMACY PRACTICE, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1078-1552
PublisherSAGE PUBLICATIONS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1995 to 2024
AbbreviationJ ONCOL PHARM PRACT / J. Oncol. Pharm. Pract.
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The JOURNAL OF ONCOLOGY PHARMACY PRACTICE focuses on optimizing pharmaceutical care in oncology, emphasizing the intersection of pharmacotherapy, patient safety, and clinical practice within cancer care. The journal aims to improve patient outcomes by disseminating research that addresses medication management, adverse drug reactions, and innovative pharmacy practices in oncology settings.
  1. Pharmaceutical Care in Oncology:
    The journal emphasizes the role of pharmacists in providing comprehensive medication management, ensuring safe and effective use of anticancer therapies, and enhancing patient education.
  2. Adverse Drug Reactions and Toxicity Management:
    Research on the identification, prevention, and management of adverse drug reactions related to cancer therapies, focusing on improving patient safety and quality of life.
  3. Clinical Pharmacy Interventions:
    The journal highlights studies on clinical pharmacy interventions, including medication reconciliation, therapeutic drug monitoring, and the integration of clinical pharmacists in oncology teams.
  4. Pharmacotherapy Research:
    The focus includes pharmacotherapy outcomes, including efficacy and safety of various cancer treatments, comparative effectiveness studies, and advancements in drug regimens.
  5. Patient-Centered Care:
    Research related to patient experience, adherence to medication, and the impact of educational interventions on cancer patients' knowledge and management of their therapies.
  6. Innovative Pharmacy Practices:
    Exploration of new methodologies in pharmacy practice, including the use of technology, telepharmacy, and automation in medication management for oncology patients.
The JOURNAL OF ONCOLOGY PHARMACY PRACTICE has increasingly shifted its focus towards emerging themes that reflect current challenges and advancements in oncology pharmacy. This trend showcases the journal's commitment to addressing contemporary issues in cancer care.
  1. Immunotherapy and Targeted Therapies:
    There is a growing emphasis on research related to immunotherapy and targeted therapies, reflecting their increasing use and complexity in cancer treatment.
  2. Pharmacogenomics and Personalized Medicine:
    Research into pharmacogenomics is on the rise, focusing on how genetic variations affect patient responses to cancer medications, promoting personalized treatment strategies.
  3. Telepharmacy and Remote Care:
    The incorporation of telepharmacy in oncology has gained traction, particularly in light of the COVID-19 pandemic, facilitating remote patient monitoring and medication management.
  4. Patient Education and Engagement:
    An increased focus on the importance of patient education and engagement strategies that enhance adherence and understanding of treatment protocols is evident.
  5. Management of Adverse Effects:
    Emerging research is increasingly centered on strategies to manage and mitigate adverse effects associated with modern cancer therapies, including immune-related adverse events.
  6. Cost-Effectiveness Studies:
    There is an upward trend in studies assessing the economic impact of cancer therapies, emphasizing the need for cost-effective treatment options in oncology.

Declining or Waning

In recent years, certain themes within the JOURNAL OF ONCOLOGY PHARMACY PRACTICE have seen a decline in focus, likely reflecting shifts in research priorities and emerging trends in oncology pharmacy practice.
  1. Traditional Chemotherapy Protocols:
    Research focused specifically on traditional chemotherapy regimens appears to be declining as newer targeted therapies and immunotherapies gain prominence.
  2. Single-Agent Studies:
    There is a noticeable decrease in publications centered on single-agent chemotherapy studies, as multi-agent and combination therapies become the focus of clinical research.
  3. Pharmacy Practice Guidelines:
    While guidelines remain important, there is a shift away from generic pharmacy practice guidelines towards more specific, evidence-based protocols tailored to individual patient needs.
  4. Focus on Pharmacokinetics Alone:
    Research that solely emphasizes pharmacokinetic studies without considering pharmacodynamics and clinical outcomes has seen less attention as a more holistic approach gains traction.
  5. Limited Scope on Complementary Therapies:
    Interest in complementary and alternative medicine approaches in oncology has waned, with a stronger emphasis on evidence-based pharmacotherapy.

Similar Journals

JOURNAL OF PHARMACY PRACTICE

Advancing pharmacy knowledge for a healthier tomorrow.
Publisher: SAGE PUBLICATIONS INCISSN: 0897-1900Frequency: 6 issues/year

JOURNAL OF PHARMACY PRACTICE, published by SAGE PUBLICATIONS INC, is a vital resource for researchers, pharmacy practitioners, and students dedicated to advancing the pharmacological and pharmaceutical sciences. Established in 1988, the journal serves as a platform for original research, reviews, and critical analyses in the fields of pharmacy and pharmacology. With an impressive impact factor and a strong presence in the Q2 category in Pharmacy and Q3 in Pharmacology (medical) as of 2023, it reflects the journal's commitment to delivering high-quality scholarly content that addresses pressing issues in pharmacy practice and medication management. The journal is indexed in Scopus, ranking #154 out of 272 in the field of Medicine and Pharmacology, positioning it within the 43rd percentile. Although it currently does not offer open access options, it remains an essential publication for those seeking to stay updated on innovations and best practices in the pharmacy sector, making it an indispensable tool for academic and professional growth.

Exploratory Research in Clinical and Social Pharmacy

Exploring the intersection of clinical and social pharmacy.
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Exploratory Research in Clinical and Social Pharmacy is a leading peer-reviewed journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmacy and its intersection with clinical and social dimensions. Since its inception in 2021, the journal has carved out an essential niche in the academic community, as reflected by its strong impact factor and reputable category rankings, including Q3 in Health, Toxicology and Mutagenesis, Q3 in Pharmacology (Medical), and Q1 in Pharmacy as of 2023. The journal aims to disseminate innovative research findings, case studies, and reviews that address contemporary challenges and solutions within the pharmacy discipline, making it a vital resource for researchers, healthcare professionals, and students alike. With its emphasis on open access, Exploratory Research in Clinical and Social Pharmacy is committed to promoting inclusive and widespread expertise within the field, facilitating collaboration and knowledge transfer across global audiences. For its readers, this journal promises to be an invaluable tool for staying updated with the latest trends and advancements in pharmacy practice and research.

JOURNAL OF PHARMACY PRACTICE AND RESEARCH

Unveiling contemporary trends in pharmacy research.
Publisher: WILEYISSN: 1445-937XFrequency: 6 issues/year

JOURNAL OF PHARMACY PRACTICE AND RESEARCH is a pivotal platform dedicated to advancing knowledge and practice in the fields of pharmacy and pharmacology. Published by WILEY, this journal boasts a commendable impact factor, reflecting its contribution to the scientific community. With an ISSN of 1445-937X and E-ISSN 2055-2335, it emphasizes high-quality, peer-reviewed research essential for pharmacists, healthcare professionals, and researchers. Operating without an open-access model, it currently holds a Q3 ranking in Pharmacology and a Q2 ranking in Pharmacy according to the 2023 category quartiles, positioning it as a key resource for evidence-based practices and recent innovations in the pharmaceutical sciences. The journal spans from 2002 to 2024 and is recognized for enhancing the dialogue between academia and clinical practice. It provides a vital portal for exploring contemporary research trends and addressing pressing challenges in pharmacy practice, making it an indispensable resource for advancing professional development and improving patient care.

Journal of Young Pharmacists

Fostering Excellence in Pharmacology and Toxicology
Publisher: INPHARM ASSOC, PHCOG NETISSN: 0975-1483Frequency: 4 issues/year

Journal of Young Pharmacists is a distinguished peer-reviewed journal published by INPHARM ASSOCIATION in collaboration with PHCOG NET. With an ISSN of 0975-1483 and an E-ISSN of 0975-1505, this journal serves as a vital platform for disseminating pioneering research in the field of pharmacology and toxicology. Although coverage in Scopus was discontinued in 2018, the journal continues to be important in educating future pharmacists and advancing the discipline, evident from its ranking in the 29th percentile among general pharmacology journals. The Journal of Young Pharmacists seeks to bridge the gap between theoretical knowledge and practical application, encouraging young researchers, professionals, and students to contribute their insights and findings. The journal emphasizes innovative approaches and contemporary issues relevant to the pharmaceutical sciences, making it an invaluable resource for anyone involved in this dynamic field.

CANADIAN JOURNAL OF HOSPITAL PHARMACY

Empowering Pharmacy Practice Through Evidence-Based Research
Publisher: CANADIAN SOC HOSPITAL PHARMACISTSISSN: 0008-4123Frequency: 4 issues/year

Canadian Journal of Hospital Pharmacy, published by the Canadian Society of Hospital Pharmacists, stands as a pivotal resource within the field of pharmacy and medical pharmacology since its inception in 1973. With its ISSN 0008-4123, this peer-reviewed journal aims to advance the knowledge and practice of hospital pharmacy through the dissemination of high-quality research, reviews, and case studies. Although currently not an open-access journal, it boasts a respectable influence in the academic community, reflected in its Q3 quartile rankings in both pharmacology and pharmacy as of 2023. Located in Ottawa, Canada, the journal encourages contributions that emphasize evidence-based practices and innovative solutions to enhance patient care. By fostering a dialogue among pharmacists, researchers, and healthcare professionals, the Canadian Journal of Hospital Pharmacy continues to be an essential platform for addressing contemporary issues and advancements in the hospital pharmacy landscape.

Pharmacy Practice-Granada

Transforming healthcare with cutting-edge pharmaceutical insights.
Publisher: CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICASISSN: 1885-642XFrequency: 4 issues/year

Pharmacy Practice-Granada is an esteemed academic journal dedicated to advancing the field of pharmacy and pharmaceutical sciences. Published by CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICAS, this journal has been a pioneer in Open Access publishing since 2006, allowing researchers worldwide to disseminate their findings without barriers. Operating out of Spain, it provides a platform for innovative research and critical discourse in pharmaceutical practice and education. As of 2023, the journal is ranked in the Q2 category for Pharmaceutical Science and holds a prestigious Q1 ranking in Pharmacy, reflecting its impact and contribution within the academic community. With a strong Scopus ranking, positioned as #6 out of 45 in Health Professions – Pharmacy and a percentile of 87%, the journal serves as a vital resource for practitioners, researchers, and students alike who are committed to enhancing health outcomes through pharmacy. With a commitment to high-quality research, Pharmacy Practice-Granada aims to support knowledge exchange and foster collaborative efforts, ultimately shaping the future of pharmaceutical care.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Transforming clinical research into therapeutic excellence.
Publisher: WILEY-HINDAWIISSN: 0269-4727Frequency: 1 issue/year

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, an esteemed publication in the field of pharmacology, is published by Wiley-Hindawi and has been at the forefront of clinical research since its inception in 1976. Operating primarily from the United Kingdom, this journal features a diverse array of articles that encompass both fundamental and practical aspects of clinical pharmacy, thereby supporting the advancement of therapeutic practices. With an ISSN of 0269-4727 and an E-ISSN of 1365-2710, it is indexed in key databases and holds respectable ranks within its categories; achieving Q3 in Pharmacology and Q2 in Medical Pharmacology in the latest quartile rankings. Its Scopus ranking reflects both its quality and relevance, being positioned in the 55th percentile for medical pharmacology and the 45th for pharmacology, toxicology, and pharmaceutics. Although it does not currently operate under an Open Access model, the journal's extensive readership and rigorous peer-review process ensure that the latest research reaches practitioners and academics alike. With a commitment to bridging the gap between pharmacological science and clinical practice, the JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS remains a critical resource for professionals striving to enhance patient outcomes through informed medication management.

Research in Social & Administrative Pharmacy

Innovating social pharmacy to enhance community health.
Publisher: ELSEVIER SCIENCE INCISSN: 1551-7411Frequency: 12 issues/year

Research in Social & Administrative Pharmacy, published by Elsevier Science Inc, is a premier academic journal that plays a pivotal role in shaping the field of pharmaceutical sciences and pharmacy practice. With an impressive impact factor and ranked in the Q1 category for both Pharmaceutical Science and Pharmacy, this journal is dedicated to the dissemination of cutting-edge research from 2005 to 2024. Targeting a diverse audience of researchers, professionals, and students, the journal covers a broad spectrum of topics including social pharmacy, policy, and administrative aspects of pharmacy practice, contributing to advancements in healthcare. As an essential resource for those engaging in pharmaceutical research, the journal upholds rigorous peer-review standards and ensures wide accessibility to influential studies that address contemporary issues in pharmacy and healthcare administration, making it an invaluable tool for knowledge enhancement and practical applications.

FARMACIA HOSPITALARIA

Elevating medication management with cutting-edge research.
Publisher: ELSEVIER SCIENCE INCISSN: 1130-6343Frequency: 6 issues/year

FARMACIA HOSPITALARIA, published by Elsevier Science Inc, is a premier open access journal that has been contributing to the fields of Medicine and Pharmacology since its inception in 1990. Based in the Netherlands, this journal provides a vital platform for the dissemination of high-quality research related to hospital pharmacy practice, medication management, and therapeutic outcomes. With an impressive scope that bridges clinical and pharmaceutical sciences, it positions itself within the 3rd quartile of both Medicine (miscellaneous) and Pharmacology categories, showcasing its relevance and evolving contributions to healthcare discourse. Since adopting an open access model in 2005, FARMACIA HOSPITALARIA has committed to making its research widely available, facilitating knowledge sharing among professionals and academics alike. Researchers and practitioners looking to stay updated with the latest advancements in pharmacy and clinical practices will find this journal an indispensable resource.

Ars Pharmaceutica

Innovating the intersection of science and the arts.
Publisher: UNIV GRANADA, EDITORIALISSN: 0004-2927Frequency: 4 issues/year

Ars Pharmaceutica is a distinguished open-access journal published by UNIV GRANADA, EDITORIAL, that has been at the forefront of pharmaceutical sciences since its establishment. With ISSN 0004-2927 and E-ISSN 2340-9894, this journal aims to disseminate high-quality research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of the field. With a historical scope that spans from 1980 to 2017, it has played a pivotal role in shaping the discourse surrounding pharmaceutical science and its intersection with the arts and humanities. Although currently ranked within the 13th percentile in Scopus for Pharmaceutical Science and the 11th percentile for History and Philosophy of Science, Ars Pharmaceutica continues to uphold its commitment to academic excellence and innovation. By providing a platform for open-access research, it encourages collaboration and knowledge sharing among researchers, professionals, and students, thus enhancing the broader understanding of pharmaceutical developments and their societal implications.